- Status Complete
- Type Re-application
- Pre-PASC consultation -
- Pre-MSAC consultation -
- Outcome Supported
Application details
Reason for application
New MBS items.
Service or technology in this application
Rapid on-demand nucleic acid amplification test for use at point-of-care in clinics servicing remote communities enabling laboratory equivalent, on-the-spot diagnosis for Chlamydia trachomatis, Neisseria gonorrhoea, and/or Trichomonas vaginalis infection within 90 minutes, facilitating antibiotic treatment for patients and initiation of contact tracing.
Type: Investigative
Medical condition this application addresses
Chlamydia trachomatis, Neisseria gonorrhoea and Trichomonas vaginalis are sexually transmitted bacterial infections, often asymptomatic, mostly affecting young people aged 15-29 years. Easily cured with antibiotics, untreated infection can cause pelvic inflammatory disease resulting in chronic abdominal pain, as well as increasing the risk of tubal infertility and ectopic pregnancy.
Previous applications
Application documents
Public summary document
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Consultation survey and deadlines
- PASC consultation: Not applicable
- MSAC consultation: Not applicable
Meetings to consider this application
- PASC meeting: Expedited – bypassing PASC
- ESC meeting: Expedited – bypassing ESC
- MSAC meeting: 23 to 24 November 2023
More information
For PICO confirmation, please see application 1627.